ctrl K

Price Alert

Arcutis Biotherapeutics I... (ARQT)

NASDAQ: ARQT · Real-Time Price · USD

16.78

0.80 (5.01%)

At close: Aug 15, 2025, 3:05 PM

Arcutis Biotherapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	71.33M	88.4M	53.64M	96.45M
Short-Term Investments	156.62M	183.46M	355.95M	290.61M
Long-Term Investments	n/a	n/a	n/a	n/a
Other Long-Term Assets	596K	596K	78K	78K
Receivables	73.07M	25.81M	8.46M	n/a
Inventory	14.53M	13.13M	7.51M	1.18M
Other Current Assets	8.82M	9.53M	4.46M	1.54M
Total Current Assets	335.82M	330.43M	437.41M	402.77M
Property-Plant & Equipment	2.99M	3.9M	4.6M	5.3M
Goodwill & Intangibles	9.48M	6.44M	7.19M	n/a
Total Long-Term Assets	13.07M	10.93M	11.87M	5.38M
Total Assets	348.89M	341.37M	449.27M	408.15M
Account Payables	14.22M	11.99M	8.83M	7.35M
Deferred Revenue	n/a	n/a	n/a	n/a
Short-Term Debt	820K	n/a	657K	433K
Other Current Liabilities	65.97M	19.07M	13.67M	15.98M
Total Current Liabilities	81.01M	46.67M	37.81M	33.33M
Long-Term Debt	107.2M	201.8M	197.77M	72.35M
Other Long-Term Liabilities	570K	849K	n/a	25K
Total Long-Term Liabilities	110.33M	206.03M	201.89M	77.15M
Total Liabilities	191.35M	252.7M	239.69M	110.47M
Total Debt	110.58M	205.92M	202.54M	77.56M
Common Stock	12K	9K	6K	5K
Retained Earnings	-1.12B	-981.9M	-719.76M	-408.31M
Comprehensive Income	-7K	4K	-1.09M	-255K
Shareholders Equity	157.54M	88.67M	209.58M	297.68M
Total Investments	156.62M	183.46M	355.95M	290.61M